The amount of money needed to get a drug to market is undeniable and extraordinary, evidenced by two Maryland biopharmaceutical companies reporting on Thursday that they lost tens of millions of dollars in 2005.
The amount of money needed to get a drug to market is undeniable and extraordinary, evidenced by two Maryland biopharmaceutical companies reporting on Thursday that they lost tens of millions of dollars in 2005.
